Edition:
United Kingdom

Kate Kelland

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

23 May 2018

Why the world needs more than one Ebola vaccine

LONDON - In the life-and-death race to make the first effective vaccine against Ebola, one company - Merck - seems bound to win.

21 May 2018

First Ebola vaccines given as WHO seeks to beat Congo outbreak

LONDON A vaccination campaign aimed at beating an outbreak of Ebola in Congo began on Monday in the port city of Mbandaka, where four cases of the deadly disease have been confirmed.

18 May 2018

In Congo outbreak, Ebola vaccine faces reality tests

LONDON An experimental Ebola vaccine to be deployed in an outbreak in Democratic Republic of Congo has conquered some major scientific hurdles in giving high protection, but it now faces extreme real-world tests including heat, humidity, language barriers and lack of roads.

17 May 2018

U.N. staff on way to Congo to get experimental Ebola vaccine

LONDON World Health Organization and other United Nations staff going to the Democratic Republic of Congo as emergency responders to an Ebola outbreak are being offered an unlicensed vaccine as protection before they go.

17 May 2018

U.N. staff on way to Congo to get experimental Ebola vaccine

LONDON World Health Organization and other United Nations staff going to the Democratic Republic of Congo as emergency responders to an Ebola outbreak are being offered an unlicensed vaccine as protection before they go.

09 May 2018

Major review backs cervical cancer shots, especially for teens

Vaccines designed to prevent infection with human papillomavirus (HPV) are effective in protecting against pre-cancerous cervical lesions in women, particularly in those vaccinated between age 15 and 26, according to a large international evidence review.

03 May 2018

Discovery of malaria parasite survival genes offers new targets

LONDON Scientists have identified the core genes that are essential for the deadliest malaria parasite to survive, revealing new targets for drugs or vaccines to fight the potentially deadly disease they cause in people.

02 May 2018

Ecstasy therapy may help service veterans suffering PTSD

Combining intensive psychotherapy with a pure form of the party drug ecstasy is safe and could aid recovery in people with post-traumatic stress disorder (PTSD), according to the findings of a study in military veterans.

26 Apr 2018

EU wants coordinated vaccine push against measles, other diseases

The European Commission urged EU member states on Thursday to cooperate more closely in fighting diseases such as measles and flu, saying vaccines against them were among the most powerful and cost-effective public health measures.

19 Apr 2018

Bill Gates backs gene technologies in fight to end malaria

LONDON Gene-editing technologies that alter mosquitoes' DNA could prove critical in the fight against malaria, Bill Gates said on Wednesday, and ethical concerns should not block progress in such gene-modifying research.

  • Europe
  • U.S.
  • Asia
  • Sectors
Stock Search
FTSE 100 7,788.44 -89.01 -1.13%
DAX 12,976.84 -193.08 -1.47%
CAC 40 5,565.85 -74.25 -1.32%
TR Europe 181.79 -3.60 -1.94%
GBP/USD 1.3354 +0.06%
GBP/EUR 1.1408 +0.00%
EUR/USD 1.1700 +0.03%
Gold 1,291.70 +0.00 +0.00%
Oil 67.50 -3.21 -4.54%
Corn 406.50 +2.25 +0.56%